BlackRock Advisors, LLC announced today that, at shareholder meetings held on October 15, 2025 and November 20, 2025, ...
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback